Home/Filings/4/0000899243-17-024464
4//SEC Filing

STARR KEVIN P 4

Accession 0000899243-17-024464

CIK 0001501989other

Filed

Oct 18, 8:00 PM ET

Accepted

Oct 19, 4:00 PM ET

Size

15.9 KB

Accession

0000899243-17-024464

Insider Transaction Report

Form 4
Period: 2017-10-18
Transactions
  • Other

    Common Stock

    2017-10-181,000,0003,320,348 total
Holdings
  • Common Stock

    145,286
  • Common Stock

    85,509
  • Common Stock

    116,927
Transactions
  • Other

    Common Stock

    2017-10-181,000,0003,320,348 total
Holdings
  • Common Stock

    116,927
  • Common Stock

    145,286
  • Common Stock

    85,509
STARR KEVIN P
10% Owner
Transactions
  • Other

    Common Stock

    2017-10-181,000,0003,320,348 total
Holdings
  • Common Stock

    85,509
  • Common Stock

    145,286
  • Common Stock

    116,927
Transactions
  • Other

    Common Stock

    2017-10-181,000,0003,320,348 total
Holdings
  • Common Stock

    85,509
  • Common Stock

    116,927
  • Common Stock

    145,286
LEVIN MARK J
10% Owner
Transactions
  • Other

    Common Stock

    2017-10-181,000,0003,320,348 total
Holdings
  • Common Stock

    116,927
  • Common Stock

    145,286
  • Common Stock

    85,509
TRV GP, LLC
10% Owner
Transactions
  • Other

    Common Stock

    2017-10-181,000,0003,320,348 total
Holdings
  • Common Stock

    116,927
  • Common Stock

    85,509
  • Common Stock

    145,286
Footnotes (5)
  • [F1]Pursuant to a Rule 10b5-1 trading plan adopted by Third Rock Ventures, L.P. ("TRV"), TRV distributed on October 18, 2017, for no consideration, 1,000,000 shares of Common Stock of the Issuer (the "Shares") to its limited partners and to Third Rock Ventures GP, L.P. ("TRV GP"), the general partner of TRV, representing each such partner's pro rata interest in such Shares. On the same date, TRV GP distributed, for no consideration, the Shares it received in the distribution by TRV to its partners, representing each such partner's pro rata interest in such Shares. All of the aforementioned distributions were made in accordance with the exemptions afforded by Rules 16a-13 and 16a-9 of the Securities Exchange Act of 1934, as amended.
  • [F2]These shares are directly held by TRV. The general partner of TRV is TRV GP. The general partner of TRV GP is TRV GP, LLC ("TRV GP LLC"). The individual managers of TRV GP LLC are Mark Levin ("Levin"), Kevin Starr ("Starr") and Dr. Robert Tepper ("Tepper"). Each of TRV GP, TRV GP LLC, Levin, Starr and Tepper disclaims beneficial ownership of the shares except to the extent of its or his pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares.
  • [F3]These shares are directly held by Starr. Includes Shares received in the distributions described in footnote (1) above.
  • [F4]These shares are directly held by Levin. Includes Shares received in the distributions described in footnote (1) above.
  • [F5]These shares are directly held by Tepper. Includes Shares received in the distributions described in footnote (1) above.

Issuer

CytomX Therapeutics, Inc.

CIK 0001501989

Entity typeother

Related Parties

1
  • filerCIK 0001192603

Filing Metadata

Form type
4
Filed
Oct 18, 8:00 PM ET
Accepted
Oct 19, 4:00 PM ET
Size
15.9 KB